Novo Nordisk, Eli Lilly stock slides after Biden op-ed calls for lower Ozempic, Wegovy Prices
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Eli Lilly, Novo Nordisk shares fall as Ozempic, Wegovy tied to rare cases of vision loss
July 3, 2024 11:49 AM EDTNovo Nordisk (NYSE: NVO) shares are down almost 4%, while Eli Lilly & Co. (NYSE: LLY) has dropped more than 1% Wednesday after a report from the New York Post said there is a potential link between Ozempic and a serious eye condition.
The publication, citing a new... More
Pharma selloff overdone: JPMorgan
July 3, 2024 7:43 AM EDTJPMorgan analysts downplayed concerns over drug pricing that triggered a broad healthcare and pharmaceutical sector sell-off, calling it "overdone election noise."
"Pricing has always been a popular issue to comment on but tough to follow through, also more complicated with the Inflation Reduction Act (IRA) now," the bank stated.... More
BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
July 2, 2024 3:04 PM EDTBMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $1,001.00 price target on Eli Lilly (NYSE: LLY).
The analyst comments "Approval of donanemab (branded Kisunla) is likely to expand revenue for both Lilly and Biogen/Eisai as two players are needed to grow infrastructure.... More
Morgan Stanley on Eli Lilly (LLY): 'we expect LLY shares to trade flat to slightly up'
July 2, 2024 2:41 PM EDTMorgan Stanley analyst Terence Flynn reiterated an Overweight rating and $1,023.00 price target on Eli Lilly (NYSE: LLY)
The analyst comments "The approval was in line with our expectations and we expect LLY shares to trade flat to slightly up as a result. For... More
Biden Says Novo Nordisk (NVO) Must Cut Ozempic, Wegovy Prices
July 2, 2024 8:00 AM EDT(Updated - July 2, 2024 8:05 AM EDT)
(Updated - July 2, 2024 8:01 AM EDT)
Biden Says Novo Nordisk (NVO) Must Cut Ozempic, Wegovy Prices
Biden Comments In USA Today Op-ed With Senator Bernie... MoreDNB Markets Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
June 30, 2024 8:01 AM EDTDNB Markets analyst Rune Majlund Dahl reiterated a Buy rating and DKK1,200.00 price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO).
... MoreNovo Nordisk (NVO) call put ratio 2.7 calls to 1 put with focus on December 150 calls
June 28, 2024 10:25 AM EDTNovo Nordisk (NYSE: NVO) 30-day option implied volatility is at 26; compared to its 52-week range of 22 to 44. Call put ratio 2.7 calls to 1 put with focus on December 150 calls.
... MoreNovo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,100 at UBS
June 28, 2024 4:34 AM EDTUBS analyst Jo Walton raised the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK1,100.00 (from DKK795.00) while maintaining a Neutral rating.... More
